Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid-related orphan nuclear receptor gamma t (RORγt) is a specific isoform of the RAR-related orphan receptor gamma (RORγ), a nuclear receptor transcription factor. RORγt, encoded by the *RORC* gene, is a master regulator of immune cell development, especially in T helper 17 (Th17) cells. It's crucial for thymocyte survival and Th17 differentiation, activating genes for IL-17A, IL-17F, and other pro-inflammatory cytokines. RORγt maintains Th17 cell identity and influences circadian rhythms. As Th17-mediated inflammation is linked to autoimmune diseases, RORγt is an attractive therapeutic target. Inhibition aims to alleviate autoimmune symptoms without broad immunosuppression. However, RORγt also plays roles in cancer and has context-dependent functions, impacting both pro-inflammatory and immunosuppressive responses.
Small molecule inhibitors targeting the ligand-binding domain have been developed experimentally to modulate its activity for therapeutic purposes against autoimmunity or cancer-associated inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid-related orphan nuclear receptor gamma t (RORγt).